Japan · Delayed Price · Currency is JPY Techno Medica Statistics
Total Valuation
Techno Medica has a market cap or net worth of JPY 15.80 billion. The enterprise value is 6.99 billion.
| Market Cap | 15.80B |
| Enterprise Value | 6.99B |
Important Dates
The next estimated earnings date is Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Techno Medica has 6.94 million shares outstanding. The number of shares has decreased by -3.38% in one year.
| Current Share Class | 6.94M |
| Shares Outstanding | 6.94M |
| Shares Change (YoY) | -3.38% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 21.98% |
| Owned by Institutions (%) | 16.40% |
| Float | 4.29M |
Valuation Ratios
The trailing PE ratio is 16.01.
| PE Ratio | 16.01 |
| Forward PE | n/a |
| PS Ratio | 1.60 |
| PB Ratio | 1.12 |
| P/TBV Ratio | 1.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.14, with an EV/FCF ratio of -28.90.
| EV / Earnings | 7.09 |
| EV / Sales | 0.71 |
| EV / EBITDA | 5.14 |
| EV / EBIT | 5.54 |
| EV / FCF | -28.90 |
Financial Position
The company has a current ratio of 6.74
| Current Ratio | 6.74 |
| Quick Ratio | 5.28 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 7.11% and return on invested capital (ROIC) is 17.84%.
| Return on Equity (ROE) | 7.11% |
| Return on Assets (ROA) | 4.78% |
| Return on Invested Capital (ROIC) | 17.84% |
| Return on Capital Employed (ROCE) | 8.75% |
| Weighted Average Cost of Capital (WACC) | 5.08% |
| Revenue Per Employee | 40.55M |
| Profits Per Employee | 4.04M |
| Employee Count | 244 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 1.86 |
Taxes
In the past 12 months, Techno Medica has paid 330.00 million in taxes.
| Income Tax | 330.00M |
| Effective Tax Rate | 25.08% |
Stock Price Statistics
The stock price has increased by +26.91% in the last 52 weeks. The beta is 0.15, so Techno Medica's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | +26.91% |
| 50-Day Moving Average | 2,140.00 |
| 200-Day Moving Average | 1,941.85 |
| Relative Strength Index (RSI) | 54.43 |
| Average Volume (20 Days) | 5,990 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Techno Medica had revenue of JPY 9.89 billion and earned 986.00 million in profits. Earnings per share was 142.29.
| Revenue | 9.89B |
| Gross Profit | 4.81B |
| Operating Income | 1.26B |
| Pretax Income | 1.32B |
| Net Income | 986.00M |
| EBITDA | 1.36B |
| EBIT | 1.26B |
| Earnings Per Share (EPS) | 142.29 |
Balance Sheet
The company has 8.81 billion in cash and n/a in debt, with a net cash position of 8.81 billion or 1,269.73 per share.
| Cash & Cash Equivalents | 8.81B |
| Total Debt | n/a |
| Net Cash | 8.81B |
| Net Cash Per Share | 1,269.73 |
| Equity (Book Value) | 14.15B |
| Book Value Per Share | 2,039.90 |
| Working Capital | 12.23B |
Cash Flow
In the last 12 months, operating cash flow was -180.00 million and capital expenditures -62.00 million, giving a free cash flow of -242.00 million.
| Operating Cash Flow | -180.00M |
| Capital Expenditures | -62.00M |
| Free Cash Flow | -242.00M |
| FCF Per Share | -34.89 |
Margins
Gross margin is 48.59%, with operating and profit margins of 12.77% and 9.97%.
| Gross Margin | 48.59% |
| Operating Margin | 12.77% |
| Pretax Margin | 13.30% |
| Profit Margin | 9.97% |
| EBITDA Margin | 13.75% |
| EBIT Margin | 12.77% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 68.00, which amounts to a dividend yield of 2.94%.
| Dividend Per Share | 68.00 |
| Dividend Yield | 2.94% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 47.77% |
| Buyback Yield | 3.38% |
| Shareholder Yield | 6.33% |
| Earnings Yield | 6.24% |
| FCF Yield | -1.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 26, 2013. It was a forward split with a ratio of 300.
| Last Split Date | Sep 26, 2013 |
| Split Type | Forward |
| Split Ratio | 300 |
Scores
Techno Medica has an Altman Z-Score of 6.25 and a Piotroski F-Score of 3.
| Altman Z-Score | 6.25 |
| Piotroski F-Score | 3 |